Skip to main content
Premium Trial:

Request an Annual Quote

Cancer Genetics to Raise $10M in Private Placement

NEW YORK – Cancer Genetics said on Thursday after the close of the market that it has signed securities purchase agreements with unnamed institutional and accredited investors to raise about $10 million through the issuance of stock and warrants.

In the private placement, Rutherford, New Jersey-based Cancer Genetics will sell 2,758,624 shares of its common stock as well as warrants to purchase an additional 2,758,624 shares.

Each share of common stock and accompanying warrant are being sold at a combined offering price of $3.625. The warrants have an exercise price of $3.50 per share, are immediately excisable, and have a term of 5.5 years.

H.C. Wainwright is acting as the exclusive placement agent for the offering.

Cancer Genetics said it expects the transaction to close around Feb. 1.

The company plans to use the net proceeds from the offering for general corporate purposes, including working capital and capital expenditures. The firm expects to have access to the proceeds following the completion of its merger with StemoniX, which is subject to stockholder approval.

In early-morning trading on the Nasdaq, Cancer Genetics' stock was down 16 percent at $4.01.

The Scan

Suicidal Ideation-Linked Loci Identified Using Million Veteran Program Data

Researchers in PLOS Genetics identify risk variants within and across ancestry groups with a genome-wide association study involving veterans with or without a history of suicidal ideation.

Algorithm Teases Out Genetic Ancestry in Individuals at Biobank Scale

Researchers develop an algorithm known as Rye to tease apart ancestry fractions in admixed individuals at a biobank-scale, applying it to 488,221 UK Biobank participants in Nucleic Acids Research.

Multi-Ancestry Analysis Highlights Comparable Common Variants at Complex Trait-Linked Loci

Researchers in Nature Genetics examine common variants implicated in more than three dozen conditions, estimating genetic effect similarities across ancestry tracts in admixed individuals.

Sick Newborns Selected for WGS With Automated Pipeline

Researchers successfully prioritized infants with potential Mendelian conditions for whole-genome sequencing or rapid whole-genome sequencing, as they report in Genome Medicine.